Agios Pharmaceuticals Inc

Market cap: $1,685,845,410

Exchange: NAS

Sector: Health Technology

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Key Statistics

Company Name

Agios Pharmaceuticals Inc

Average Volume (10 days)

710,071

Average Volume (30 days)

964,727

Moving Average (50 days)

$27.79

Moving Average (200 days)

$24.4

Ex-Divided Date

n/a

Dividend Yield

0

P/E Ratio

1.0525

Market Cap

1,685,845,410

Shares Outstanding

56,194,847

52-Week High Split Adjust Only

35.5

52-Week Low Split Adjust Only

19.8

Employee Count

883

Beta

1.1681

Next Earnings Date

2024-05-02

TTM Dividend Rate Per Share

0

Price Changes

Past 5 days

-0.06%

Past 30 days

0.19%

Past 3 months

0.32%

Past 6 months

0.1%

Past year

0.33%

Past 2 years

0.05%

Past 5 years

-0.54%

Max % Change

-0.04%

PEER GROUP COMPARATIVE PERFORMANCE

NameTickerPrice/Sales (ttm)Price/Book (ttm)Forward P/EPEG RatioEV/Revenue
Agios Pharmaceuticals IncAGIO29.581.50n/a29.589.47
Peer AvgN/A7.577.67-22.57.576.92
Lilly(Eli) & CoLLY7.5227.7725.27.528.03
Pfizer Inc.PFE4.883.1610.24.885.46
Glaxosmithkline plc - ADRGSK2.104.91n/a2.102.71
Biomarin Pharmaceutical Inc. - Registered SharesBMRN7.663.39-151.27.667.65
Exelixis IncEXEL5.222.96-0.05.224.06
Xencor IncXNCR18.023.84-19.318.0213.58